The U.S. Food and Drug Administration today approved INVEGA Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia.
From: biz.yahoo.com
TM) for Long-Term Maintenance Treatment of Schizophrenia
Posted by Ruslan Abuzant at 11:26 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment